{
    "Trade/Device Name(s)": [
        "Chemtrue\u00ae Drug Screen Cup Tests",
        "Chemtrue\u00ae Drug Screen Cup Tests with OPI 2000"
    ],
    "Submitter Information": "Chemtron Biotech, Inc.",
    "510(k) Number": "K143599",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061718",
        "K060896",
        "K142396",
        "CR140334"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "LFG",
        "DKZ",
        "DIO",
        "LDJ",
        "DNK",
        "LAF",
        "LCM",
        "JXM",
        "DIS",
        "DJC",
        "DJR"
    ],
    "Summary Letter Date": "April 9, 2015",
    "Summary Letter Received Date": "April 13, 2015",
    "Submission Date": "April 15, 2015",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3910",
        "21CFR862.3100",
        "21CFR862.3250",
        "21CFR862.3610",
        "21CFR862.3640",
        "21CFR862.3870",
        "21CFR862.3170",
        "21CFR862.3150",
        "21CFR862.3620"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Tricyclic Antidepressants test system",
        "Amphetamine Test System",
        "Cocaine and metabolites Test System",
        "Methamphetamine Test System",
        "Morphine Test System",
        "Cannabinoids Test System",
        "Benzodiazepines Test System",
        "Barbiturates Test System",
        "Methadone Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "Amphetamine",
        "Cocaine",
        "Marijuana",
        "Morphine",
        "Opiates 2000",
        "Methamphetamine",
        "Phencyclidine",
        "Benzodiazepines",
        "Barbiturates",
        "Ecstasy (MDMA)",
        "Methadone",
        "Oxycodone",
        "Tricyclic Antidepressants"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Colloidal gold-based immunoassay"
    ],
    "Methodologies": [
        "Lateral flow",
        "Competitive binding immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Panel",
        "Cup",
        "In vitro diagnostic device"
    ],
    "Document Summary": "FDA 510(k) summary for Chemtron Biotech Chemtrue Drug Screen Cup Tests and Chemtrue Drug Screen Cup Tests with OPI 2000 for qualitative detection of drugs of abuse in human urine using lateral flow immunoassay.",
    "Indications for Use Summary": "Rapid qualitative detection of multiple drugs of abuse (Buprenorphine, Amphetamine, Cocaine, Marijuana, Morphine, Opiates 2000, Methamphetamine, Phencyclidine, Benzodiazepines, Barbiturates, Ecstasy, Methadone, Oxycodone, Tricyclic Antidepressants) in human urine for prescription and over-the-counter use.",
    "fda_folder": "Toxicology"
}